PlaySide Studios is shifting from contract development to original IP and publishing to boost margins and growth. Strong partnerships and a solid pipeline support optimism, but revenue volatility and past unprofitability keep investor sentiment cautious.
Orthocell is a regenerative medicine company expanding Remplir globally, but investors remain cautious because revenue growth is uneven, the business is still loss-making, and U.S. uptake may take time, leaving the stock a higher-risk turnaround opportunity.
Lynas Rare Earths (ASX: LYC) recently broke its short-term uptrend due to weak Q3 production, facility outages, and expansion costs. Technical analysis indicates strong downside momentum, with the next major support zone sitting lower around the $16.00–$16.23 level.
Nuix remains in a weak downtrend despite a bounce toward ~$1.5. The stock is consolidating between ~$1.1–$1.5, showing stabilisation but no confirmed bottom. A breakout above resistance is needed, with risks still skewed to the downside.
Strike Energy Limited is a Perth Basin gas producer transitioning into gas-to-power and new energy. Improving reserves, project progress, and stronger pricing may signal a recovery, while shares rebound from long-term lows as momentum strengthens.
This ASX gold producer is undervalued due to limited production history, but strong early margins suggest significant profit potential and a possible near-term re-rating. It operates a low-risk open-pit mine with long reserves, resources, and added silver by-product exposure.
...
